buprenorphine taper followed by naltrexone maintenance
R01DA019989
Phase 2 small_molecule completed
Quick answer
buprenorphine taper followed by naltrexone maintenance for Prescription Opioid Dependence is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Prescription Opioid Dependence
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed